Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Applications of ellagic acid in preparation of immunomodulatory medicines for treatment of neuromyelitis optica or immune rejection after skin transplantation

Applications of ellagic acid in preparation of immunomodulatory medicines for treatment of neuromyelitis optica or immune rejection after skin transplantation

US Patent 11944601 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of miloxacin in preparation of medicines for treating and/or preventing dise2025
Near-infrared photothermally activated CRISPR/CAS9 genome editing machine2024
Toxoplasma gondii vaccines and their use2024
Silica composite monolith as a solid phase extraction material2023
BCKDK inhibitors2023
Amphoteric compounds2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors2022
Reconfigurable joint track compound mobile robot2022
BCKDK inhibitors2021
Complex bacteria for improving corn steeping effects and usage thereof2021
Skylight operating system of modular data center2021
Lipid nanoparticles and use thereof to deliver RNA polynucleotides2021